"SUMO-1 Protein" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A 1.5-kDa small ubiquitin-related modifier protein that can covalently bind via an isopeptide link to a number of cellular proteins. It may play a role in intracellular protein transport and a number of other cellular processes.
| Descriptor ID |
D025842
|
| MeSH Number(s) |
D12.776.947.249.500
|
| Concept/Terms |
SUMO-1 Protein- SUMO-1 Protein
- SUMO 1 Protein
- Gap-modifying Protein 1
- Gap modifying Protein 1
- PIC 1 Protein
- PIC1 Protein
- Ubiquitin-like 1 Gene Product
- Ubiquitin like 1 Gene Product
- Protein GMP1
- GMP1, Protein
- Sentrin
- Sentrin 1
- SMT3C Protein
- SUMO Protein
- UBL1 Protein
- PML-Interacting Clone Protein
- PML Interacting Clone Protein
|
Below are MeSH descriptors whose meaning is more general than "SUMO-1 Protein".
Below are MeSH descriptors whose meaning is more specific than "SUMO-1 Protein".
This graph shows the total number of publications written about "SUMO-1 Protein" by people in this website by year, and whether "SUMO-1 Protein" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2002 | 3 | 0 | 3 |
| 2004 | 2 | 1 | 3 |
| 2005 | 0 | 1 | 1 |
| 2008 | 2 | 0 | 2 |
| 2009 | 1 | 0 | 1 |
| 2011 | 1 | 2 | 3 |
| 2013 | 1 | 0 | 1 |
| 2015 | 1 | 0 | 1 |
| 2016 | 1 | 0 | 1 |
| 2017 | 0 | 1 | 1 |
| 2019 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "SUMO-1 Protein" by people in Profiles.
-
Epstein-Barr Virus Latent Membrane Protein-1 Induces the Expression of SUMO-1 and SUMO-2/3 in LMP1-positive Lymphomas and Cells. Sci Rep. 2019 01 18; 9(1):208.
-
Novel signal transducer and activator of transcription 1 mutation disrupts small ubiquitin-related modifier conjugation causing gain of function. J Allergy Clin Immunol. 2018 05; 141(5):1844-1853.e2.
-
SUMO Modification Reverses Inhibitory Effects of Smad Nuclear Interacting Protein-1 in TGF-? Responses. J Biol Chem. 2016 Nov 18; 291(47):24418-24430.
-
Structurally distinct ubiquitin- and sumo-modified PCNA: implications for their distinct roles in the DNA damage response. Structure. 2015 Apr 07; 23(4):724-733.
-
De-SUMOylation enzyme of sentrin/SUMO-specific protease 2 regulates disturbed flow-induced SUMOylation of ERK5 and p53 that leads to endothelial dysfunction and atherosclerosis. Circ Res. 2013 Mar 15; 112(6):911-23.
-
PIAS1 is a GATA4 SUMO ligase that regulates GATA4-dependent intestinal promoters independent of SUMO ligase activity and GATA4 sumoylation. PLoS One. 2012; 7(4):e35717.
-
PKC? mediates disturbed flow-induced endothelial apoptosis via p53 SUMOylation. J Cell Biol. 2011 May 30; 193(5):867-84.
-
Defective sumoylation pathway directs congenital heart disease. Birth Defects Res A Clin Mol Teratol. 2011 Jun; 91(6):468-76.
-
SUMO-targeted ubiquitin ligase, Rad60, and Nse2 SUMO ligase suppress spontaneous Top1-mediated DNA damage and genome instability. PLoS Genet. 2011 Mar; 7(3):e1001320.
-
Adenosine signaling mediates SUMO-1 modification of IkappaBalpha during hypoxia and reoxygenation. J Biol Chem. 2009 May 15; 284(20):13686-13695.